SCHEMBL7095263

SCHEMBL7095263

CCN(CC)C(=O)Nc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.66
KMT2A Q03164 2/20 0.66
ALDH1A1 P00352 3/20 0.65
NPSR1 Q6W5P4 2/20 0.65
RAB9A P51151 3/20 0.58
POLB P06746 2/20 0.58
NPC1 O15118 2/20 0.58
TP53 P04637 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
CA12 O43570 1/20 0.58
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
CA9 Q16790 1/20 0.58
KDM4E B2RXH2 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
HSD17B10 Q99714 3/20 0.57
LMNA P02545 1/20 0.56
TSHR P16473 1/20 0.56
NOX1 Q9Y5S8 1/20 0.56
ABCC1 P33527 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9480181 0.93 MAPT (0.62) MEN1KMT2AALDH1A1NPSR1RAB9A
SCHEMBL3302544 0.90 POLB (0.69) MEN1KMT2AALDH1A1NPSR1RAB9A
SCHEMBL25230837 0.89 NPSR1 (0.60) MEN1KMT2AALDH1A1NPSR1RAB9A
SCHEMBL5838457 0.88 NPSR1 (0.59) MEN1KMT2AALDH1A1NPSR1RAB9A
SCHEMBL7753723 0.86 NPSR1 (0.61) MEN1KMT2AALDH1A1NPSR1RAB9A
SCHEMBL25272620 0.86 HDAC6 (0.62) MEN1KMT2AALDH1A1NPSR1TP53
SCHEMBL25277617 0.85 HDAC6 (0.57) MEN1KMT2AALDH1A1NPSR1CA12
SCHEMBL10596118 0.85 ALDH1A1 (0.61) MEN1KMT2AALDH1A1NPSR1POLB
Hydrochloric Acid SCHEMBL11421352 0.85 CA12 (0.68) MEN1KMT2AALDH1A1RAB9APOLB
SCHEMBL11186133 0.84 MEN1 (0.57) MEN1KMT2AALDH1A1NPSR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170260187-A1 NEW AGENTS FOR TREATING NEUROGENIC INFLAMMATION AND NEUROPATHIC HYPERALGESIA RELATED DISORDERS PÉCSI TUDOMÁNYEGYETEM (HU) 2017-09-14 US claimed
EP-3194399-A1 NEW AGENTS FOR TREATING NEUROGENIC INFLAMMATION AND NEUROPATHIC HYPERALGESIA RELATED DISORDERS Pécsi Tudományegyetem (HU) 2017-07-26 EP claimed
WO-2016042349-A1 NEW AGENTS FOR TREATING NEUROGENIC INFLAMMATION AND NEUROPATHIC HYPERALGESIA RELATED DISORDERS PÉCSI TUDOMÁNYEGYETEM (HU) 2016-03-24 WO claimed
EP-4446310-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND Asahi Kasei Kabushiki Kaisha (JP) 2024-10-16 EP disclosed
CN-118382612-A Method for producing blocked isocyanate compound and method for producing isocyanate compound 旭化成株式会社 2024-07-23 CN disclosed
CN-117383994-A Preparation method of asymmetric urea compound and asymmetric urea compound 内蒙古工业大学 2024-01-12 CN disclosed
WO-2023106377-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND 旭化成株式会社 2023-06-15 WO disclosed
US-20230159743-A1 HEAT-CURABLE EPOXY RESIN COMPOSITION AND HEAT-CURABLE EPOXY RESIN SHEET SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-05-25 US disclosed
US-20230140883-A1 NOVEL MEMBRANES AND PREPARATION THEREOF IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2023-05-11 US disclosed
US-20230140883-A1 NOVEL MEMBRANES AND PREPARATION THEREOF IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2023-05-11 US disclosed
US-10808102-B2 Thermosetting epoxy resin sheet for encapsulating semiconductor, semiconductor equipment, and method for manufacturing the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-10-20 US disclosed
US-4888321-A SUBBING AND RECORDING LAYERS EACH CONTAINING HEAT FUSIBLE MATERIAL WITH DEFINED MELTING POINT FUJI PHOTO FILM CO., LTD. (JP) 1989-12-19 US disclosed
US-4871871-A DECOMPOSING AROMATIC BISDIALKYL UREA WITH TERTIARY AMINE SALT PROMOTER IN SOLVENT ARCO CHEMICAL TECHNOLOGY, INC. (US) 1989-10-03 US disclosed
EP-0328411-A2 Composition for vibration damper, process for manufacture thereof, and vibration damper MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1989-08-16 EP disclosed
US-4533929-A ANIONIC SURFACTANTS AS ANTIFOGGING AGENTS; DIETHYLHEXYL SULFOSUCCINATE FUJI PHOTO FILM CO., LTD. (JP) 1985-08-06 US disclosed
US-4520377-A COLOR FORMING LAYER COMO/SED OF ELECTRON DONATING COLORLESS DYE, ELECTRON ACCEPTING COMPOUND, NAPHTHOL UREA AND/OR URETHANE DERIVATIVE FUJI PHOTO FILM CO., LTD. (JP) 1985-05-28 US disclosed
US-4401717-A CONTAINING A CHROMOGEN, A PHENOL LAND A UREA OR CARBAMATE; THERMOGRAPHY FUJI PHOTO FILM CO., LTD. (JP) 1983-08-30 US disclosed
EP-0020052-A1 Novel substituted nitrodiphenyl ethers, herbicidal compositions containing them, processes for the preparation thereof and the use thereof for combating weeds ROHM AND HAAS COMPANY (US) 1980-12-10 EP disclosed
US-4122090-A Cyclic esters of 3,4-dihydroxy-thiophene-1,1-dioxide compounds and 3,4-dihydroxy-cyclopentadienone compounds BASF AKTIENGESELLSCHAFT (DE) 1978-10-24 US disclosed
US-4052454-A PROCESS FOR THE MANUFACTURE OF UREAS ATLANTIC RICHFIELD COMPANY (US) 1977-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170260187-A1 NEW AGENTS FOR TREATING NEUROGENIC INFLAMMATION AND NEUROPATHIC HYPERALGESIA RELATED DISORDERS TRPV1, P2RX3, P2RX4 MEN1 4866/4885KMT2A 3486/4885ALDH1A1 939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.